Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment

Arsenic trioxide has been successfully used as a therapeutic in the treatment of acute promyelocytic leukemia (APL). Detailed monitoring of the therapeutic arsenic and its metabolites in various accessible specimens of APL patients can contribute to improving treatment efficacy and minimizing arseni...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Baowei, Cao, Fenglin, Yuan, Chungang, Lu, Xiufen, Shen, Shengwen, Zhou, Jin, Le, X. Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2013
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565090/
https://www.ncbi.nlm.nih.gov/pubmed/23318765
http://dx.doi.org/10.1007/s00216-012-6700-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565090/
https://www.ncbi.nlm.nih.gov/pubmed/23318765
http://dx.doi.org/10.1007/s00216-012-6700-5

Ejemplares similares